IGWM
CLRB icon

ICA Group Wealth Management’s Cellectar Biosciences CLRB Stock Holding History

ICA Group Wealth Management’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12
Closed -$1.39K – 864
2024
Q1 		$1.39K Buy
+12
New +$1.3K ﹤0.01% 1214

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICA Group Wealth Management's CLRB Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Cellectar Biosciences (CLRB) in Q2 2024, closing a stake of 12 shares — an estimated $1.39K sold.

ICA Group Wealth Management first reported a position in CLRB in Q1 2024 and held it in 1 quarter. The position peaked at $1.39K in Q1 2024. 37 funds tracked by Wall St. Rank hold CLRB as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Cellectar Biosciences position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 12 Cellectar Biosciences shares in Q2 2024, an estimated $1.39K.
  • ICA Group Wealth Management first reported a position in Cellectar Biosciences in Q1 2024 and held it in 1 quarter.
  • ICA Group Wealth Management's Cellectar Biosciences position peaked at $1.39K in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.